NNuubo
Nuubo is a Spanish medical device company that develops a wearable, non-invasive cardiac monitoring system based on textile electrodes: the Nuubo30 smart garment, the NuuboREC wireless ECG recorder, and the Leonardo software platform for real-time signal analysis. Founded in 2005 and headquartered in Madrid with R&D and manufacturing in Valencia, it targets ambulatory/long-term ECG monitoring (arrhythmia detection, stroke units, cardiology departments) and has expanded to the US market. It is a mature, venture-backed medtech company that raised roughly €8-9M across rounds up to about 2018.
SectorsHealthtech & Bio, Medical Devices, Wearables, Digital Health, Remote Patient Monitoring
Start-up MapHealthtech & Bio › Medical devices & surgical hardware
Founders
L
Luis Sánchez Morales
Co-founder & CFO/COO
Global models 5
IiRhythm Technologies
United States · www.irhythmtech.com ↗
Sells wearable long-term ambulatory ECG monitoring (the Zio patch) plus algorithmic analysis software to cardiology practices and hospitals for arrhythmia detection.
~$200MComparable
VVitalConnect
United States · vitalconnect.com ↗
Wearable wireless biosensor and software platform for extended cardiac monitoring and arrhythmia detection, sold to hospitals and cardiologists.
~$150MComparable
I
InfoBionic
United States · infobionic.com ↗
Wearable remote ECG monitor with a cloud platform for real-time arrhythmia analysis, sold to cardiology practices.
~$100MComparable
BBardy Diagnostics
United States · www.bardydx.com ↗
Non-invasive wearable ECG patch for long-term ambulatory monitoring, with software and diagnostic reports for cardiologists.
~$90MComparable
NNanowear
United States · www.nanowearinc.com ↗
Textile-based sensor garment (SimpleSense) for non-invasive continuous cardiac monitoring, closest to Nuubo's smart-textile approach.
~$45MComparable
In the same niche 72 others
See all in the Start-ups Map →
AAnaconda Biomed
Sant Cugat del Vallès
Series C (estimated) · €90.1M
IINBRAIN Neuroelectronics
Barcelona
Series B (estimated) · €84.5M
OOverture Life
Madrid
Venture Debt · €71.2M
M
Medlumics
Madrid
No stage disclosed · €57.8M
AAortyx
Barcelona
Series A · €16.9M
GGeniova
Madrid
Series A (estimated) · €16.1M
Notes: Most funded first
Investors 6
Open as list →Funding rounds 6
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-10-15 | Series B (estimated) | €3.23M partial: only one investor's ticket was disclosed |
Lead not disclosed
+2 more
|
| 2024-05-31 | No stage disclosed | €721K partial: only one investor's ticket was disclosed |
Nuubo Investments FCRE
+1 more
|
| 2024-05-30 | Series B (estimated) | €721K partial: only one investor's ticket was disclosed |
Nuubo Investments FCRE
+1 more
|
| 2023-11-07 | Series A (estimated) | €603K | CDTI Innovación (Innvierte), Nuubo Investments FCRE (CRB Inverbío) |
| 2022-10-10 | Series A (estimated) | approximately €8M |
Nuubo Investments FCRE (estimated lead)
+4 more
|
| 2014-05 | Series A (estimated) | €3M |
Caixa Capital Risc (Caixa Innvierte BioMed II), CRB Inverbio (CRB Bio II)
+1 more
|
News
No coverage on record yet.



